Clinical Trial

Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated September 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
Along with the current clinical trial, the efficacy and safety of a 300 mg loading dose of clopidogrel and 300 mg loading aspirin administered within 24 hours of the first-ever large-vessel minor stroke or TIA compared to 200 mg cilostazol and 300 mg loading aspirin were assessed through NIHSS, mRS, and possible adverse effects
Trial Details
NCT Number NCT06591351
Lead Sponsor Kafrelsheikh University
Conditions Ischemic Stroke
Enrollment 870 participants
Start Date 2022-05-01
Primary Completion 2024-09-30 (estimated)
Study Completion 2024-10-10 (estimated)
Updated on ClinicalTrials.gov 2024-09-19